Table of Contents
Guy Hatchard
Guy is an international advocate of food safety and natural medicine. He received his undergraduate degree in logic and theoretical physics from the University of Sussex and his PhD in psychology from Maharishi University of Management, Fairfield Iowa. He was formerly a senior manager at Genetic ID, a global food safety testing and certification laboratory.
On the Friday before Christmas, Health New Zealand quietly released the 2023 New Zealand cancer data to a media preoccupied with end of year holiday trivia. Not surprisingly, the figures received exactly zero press coverage. The Hatchard Report has released an updated version of our analysis on our Substack channel. In terms of historical trends, the figures contain alarming information that points to our worst fears. The trend included an eight per cent increase in cancer rates among mature working adults.
Rate of new cancer registrations in New Zealand per 1000 population
The New Zealand data is not an isolated finding. Official figures from England show an almost identical trend. New cancer registration rates per 1000 population for the 0-64 age range in 2023 (the latest available figures) are up 8.8 per cent compared to the average pre-pandemic rate for 2015–2019. In other words, as in NZ, the burden of cancer incidence in England is increasingly falling upon younger age groups including working age adults. This is a novel and alarming trend, but health authorities have largely chosen to remain silent or blame it on the usual suspects.
The trend in the UK is confirmed by oncologist Prof Angus Dalgleish who reports in an interview with Neil Oliver at GB News a startling rise in melanoma relapse rates among those who received a Covid-19 booster vaccine. According to Dalgleish this is affecting even some who had been in remission and cancer free for decades. Relapse rates among cancer patients in remission are not included in the annual new cancer registration data. This shows that the actual rise in cancer incidence may be higher than the 2023 figures indicate. Dalgleish describes his findings as a “red flag”, just as we described the latest New Zealand data as a red flag, at the very least pointing to vaccine induced immune exhaustion.
A RED FLAG means what it always has: STOP IMMEDIATELY, reassess and take urgent remedial action.
The last available new cancer registration figures for the whole of Australia date to 2021, four years behind, but the state of Victoria has released figures including 2024, data which is at an historical record high and also featuring disturbingly increased rates among working age adults.
Unbelievably, figures from Canada are even more out of date, ending in 2020 (?). Recent published assessments are largely misleading projections based on out of date pre-pandemic trends. This tardy and inadequate approach to public health monitoring is being pursued despite published studies conducted in Korea, Japan and Italy linking Covid-19 vaccination with elevated cancer incidence or complication. The overall picture is one of a well-paid army of health bureaucrats compiling figures years out of date and then not even bothering or caring to assess the obvious implications. Instead blaming any rise on an ageing population without crunching the data and doing the maths.
Almost five years ago, biotech researchers with the support of the global pharmaceutical industry and governments around the world launched a forced global vaccination program affecting billions of people involving novel biotechnology. Dozens of types of novel bio-vaccines were used for the first time on humans. There had already been discernible red flags following animal and then human trials, but they were ignored. Why? We now know Covid-19 vaccination was a reckless experiment that went horribly wrong. It was associated with a record level of proximate adverse effects including cardiac disease, strokes, neurological illness, kidney disease, reproductive issues, immunological disease and mental illness.
The latest cancer data opens up another chapter in the ongoing Covid-19 vaccination saga of adverse effects and excess deaths. As many, including the Hatchard Report, warned right from the start, there will be long-term effects. It appears these are now materialising. A trend that governments are very anxious to hide. There couldn’t have been a more obvious indication of an attempt at misdirection than the award in the New Zealand New Years Honours List of Knight Companion to Professor Graham Le Gros for contributions to medicine. Le Gros famously told the NZ Royal Commission on Covid-19 Phase 2 that the clinical trials of the Covid-19 mRNA vaccine were not rushed and were sufficient to show it was safe and effective. How could they be sufficient? There was and has been since no controlled assessment of long term outcomes.
The take home result of the long running Covid-19 vaccine saga is clear. Biotechnologists incorrectly predicted the novel genetic style of vaccination would be effective at prevention of transmission and it would be safe. They were not just wrong, they were fundamentally wrong. The pandemic outcomes have revealed our current understanding of genetic functions and their interaction with the immune system is deficient. It is incomplete. At this point in time, any attempt to prevent or obscure the need for a vigorous reassessment of pandemic outcomes across the entire spectrum of major medical conditions comparing vaccinated and unvaccinated amounts to nothing less than medical negligence and reckless disregard of public health.
Our new year call is for an end to the mRNA vaccine harm cover up and a systemic purging of the inertia and indifference affecting our moribund medical establishment. Continuing to assert that Covid-19 vaccine harm is unproven whilst encouraging booster uptake and refusing to study comparative data has long since become an untenable position. In 2026 we aim to bring the unequivocal data to the attention of all those taking public health decisions.
This article was originally published by the Hatchard Report.
